Transient Suppression of Dopamine Transporter Palmitoylation by Methamphetamine: Implications for Transport Regulation
Authors:
- Moriah J. HovdeMHMoriah J. Hovde
- Danielle E. BollandDBDanielle E. Bolland
- Corey D. KleinsasserCKCorey D. Kleinsasser
- Madhur ShettyMSMadhur Shetty
- Aaron C. BlackwellABAaron C. Blackwell
- Mikhail Y. GolovkoMGMikhail Y. Golovko
- Svetlana A. GolovkoSGSvetlana A. Golovko
- Christopher R. BrownCBChristopher R. Brown
- James D. FosterJFJames D. Foster
- Roxanne A. VaughanRVRoxanne A. Vaughan
Preprint
Abstract
The dopamine transporter (DAT) exerts temporal and spatial control over dopaminergic neurotransmission through reuptake of extracellular dopamine (DA). The functional capacity of DAT is under the control of signaling inputs and post-translational modifications that confer acute presynaptic regulation of reuptake in response to physiological needs, and dysregulation of these processes may contribute to DA imbalances in mood disorders and drug addiction. A key modification of DAT is palmitoylation, a lipid adduction that enhances transport velocity, is suppressed by protein kinase C, and opposes protein kinase C-mediated down-regulation. Here we now show in rat striatum and heterologous cells that transporter palmitoylation is also linked to methamphetamine (METH), undergoing rapid and transient reductions in response to the drug. The time course and other characteristics of palmitoylation reduction parallel those of METH-induced transport down-regulation, and a palmitoylation-deficient DAT mutant shows enhanced down-regulation to METH, supporting a mechanistic link between reduction of the modification and reduced reuptake activity. Recovery rates differed, however, with palmitoylation returning to starting levels more rapidly than reuptake, indicating that down-regulation mechanisms remain engaged with transporters that have undergone repalmitoylation. These results support palmitoylation as a rapid response mechanism that modulates DAT entry into METH-induced down-regulation states and suggest a broader role for the modification in control of reuptake in additional physiological and pathophysiological conditions.Keywords
All Related Versions
- Published version: The FASEB Journal, 39 (21), e71194.
Funding Information
- National Institute on Drug Abuse (2R15DA031991-02A1)
- National Institute of General Medical Sciences (P20GM103442)
- National Institute of General Medical Sciences (P20GM104360)
- National Science Foundation (OIA-1355466)
This publication has 70 references indexed in Scilit:
- Dopamine transporter membrane mobility is bidirectionally regulated by phosphorylation and palmitoylationCurrent Research in Physiology, 2023
- Rapid Brain Distribution of Subcutaneously Administered Methamphetamine in MiceEuropean Journal of Drug Metabolism and Pharmacokinetics, 2022
- Neurotoxicity of methamphetamine: Main effects and mechanismsExperimental Neurology, 2021
- Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activityJournal of Biological Chemistry, 2021
- Protein palmitoylation and its pathophysiological relevanceJournal of Cellular Physiology, 2020
- Structural determinants of protein partitioning into ordered membrane domains and lipid raftsChemistry and Physics of Lipids, 2015
- Good riddance to dopamine: Roles for the dopamine transporter in synaptic function and dopamine-associated brain disordersNeurochemistry International, 2014
- SLC6 transporters: Structure, function, regulation, disease association and therapeuticsMolecular Aspects of Medicine, 2013
- Relevance of pharmacokinetic parameters in animal models of methamphetamine abuseSynapse, 2000
- Protein kinase C and dopamine transport—2. Effects of amphetamine in vitroNeuropharmacology, 1992